NO2470168T3 - - Google Patents
Info
- Publication number
- NO2470168T3 NO2470168T3 NO10747777A NO10747777A NO2470168T3 NO 2470168 T3 NO2470168 T3 NO 2470168T3 NO 10747777 A NO10747777 A NO 10747777A NO 10747777 A NO10747777 A NO 10747777A NO 2470168 T3 NO2470168 T3 NO 2470168T3
- Authority
- NO
- Norway
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27526909P | 2009-08-26 | 2009-08-26 | |
PCT/US2010/046503 WO2011025785A1 (en) | 2009-08-26 | 2010-08-24 | Methods for the prevention and treatment of cerebral ischemia |
Publications (1)
Publication Number | Publication Date |
---|---|
NO2470168T3 true NO2470168T3 (de) | 2018-06-30 |
Family
ID=42983642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO10747777A NO2470168T3 (de) | 2009-08-26 | 2010-08-24 |
Country Status (17)
Country | Link |
---|---|
US (3) | US20110207828A1 (de) |
EP (1) | EP2470168B1 (de) |
JP (2) | JP5785546B2 (de) |
CN (1) | CN102647981B (de) |
AU (1) | AU2010286704B2 (de) |
BR (1) | BR112012004167A2 (de) |
CA (1) | CA2772294C (de) |
DK (1) | DK2470168T3 (de) |
EA (1) | EA028677B1 (de) |
ES (1) | ES2663709T3 (de) |
HU (1) | HUE037592T2 (de) |
MX (1) | MX337990B (de) |
NO (1) | NO2470168T3 (de) |
PL (1) | PL2470168T3 (de) |
PT (1) | PT2470168T (de) |
SI (1) | SI2470168T1 (de) |
WO (1) | WO2011025785A1 (de) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7514461B2 (en) | 2003-09-19 | 2009-04-07 | Edison Pharmaceuticals, Inc. | Chroman derivatives |
DK1888059T3 (en) * | 2005-06-01 | 2015-03-30 | Edison Pharmaceuticals Inc | Redox-active therapeutic products for the treatment of mitochondrial diseases and other conditions as well as modulation of energy biomarkers |
EA019675B1 (ru) | 2006-02-22 | 2014-05-30 | Эдисон Фармасьютикалз, Инк. | Редокс-активные терапевтические средства для лечения митохондриальных заболеваний и модуляции биомаркера коэнзима q |
EP2220030B1 (de) | 2007-11-06 | 2016-01-13 | Edison Pharmaceuticals, Inc. | 4-(p-chinonyl)-2-hydroxybutanamidderivate zur behandlung von mitochondrialen krankheiten |
WO2009089224A1 (en) | 2008-01-08 | 2009-07-16 | Edison Pharmaceuticals, Inc. | (HET) ARYL-p-QUINONE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES |
WO2009111576A2 (en) | 2008-03-05 | 2009-09-11 | Edison Pharmaceuticals, Inc. | 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES |
US8716486B2 (en) * | 2008-06-25 | 2014-05-06 | Edison Pharmaceuticals, Inc. | 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
US8314153B2 (en) | 2008-09-10 | 2012-11-20 | Edison Pharmaceuticals, Inc. | Treatment of pervasive developmental disorders with redox-active therapeutics |
US10039722B2 (en) | 2008-10-14 | 2018-08-07 | Bioelectron Technology Corporation | Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells |
PL2963006T3 (pl) | 2008-10-28 | 2019-01-31 | Bioelectron Technology Corporation | Kompozycja zawierająca chinon alfa-tokotrienolu, i jego związki pośrednie |
NO2424495T3 (de) | 2009-04-28 | 2018-06-16 | ||
EP2519232A1 (de) * | 2009-12-31 | 2012-11-07 | Edison Pharmaceuticals, Inc. | Behandlung von leigh-syndrom und leigh-like-syndrom mit tocotrienolchinonen |
AU2011245384C1 (en) * | 2010-04-27 | 2016-09-01 | Bioelectron Technology Corporation | Formulations of quinones for the treatment of ophthalmic diseases |
US9464016B2 (en) | 2011-06-14 | 2016-10-11 | Edison Pharmaceuticals, Inc. | Catechol derivatives for treatment of oxidative stress diseases |
EP2734512B1 (de) | 2011-07-19 | 2019-11-20 | Bioelectron Technology Corporation | Verfahren zur selektiven oxidation von alpha-tocotrienol in gegenwart von nicht-alpha-tocotrienolen |
GB201117808D0 (en) * | 2011-10-14 | 2011-11-30 | Siemens Medical Solutions | SUV correction following dose infiltration |
CN104507309B (zh) | 2012-03-19 | 2017-05-03 | 奇达拉治疗公司 | 用于棘白菌素类化合物的给药方案 |
CA2883882A1 (en) | 2012-09-07 | 2014-03-13 | Edison Pharmaceuticals, Inc. | Benzoquinone derivatives for treating oxidative stress disorders |
PT2919777T (pt) * | 2012-11-13 | 2020-03-30 | Invictus Biotechnology Pty Ltd | Distribuição transmucosa de tocotrienol |
US9670170B2 (en) | 2013-03-15 | 2017-06-06 | Bioelectron Technology Corporation | Resorufin derivatives for treatment of oxidative stress disorders |
US9296712B2 (en) | 2013-03-15 | 2016-03-29 | Edison Pharmaceuticals, Inc. | Resorufin derivatives for treatment of oxidative stress disorders |
EP2970158B1 (de) | 2013-03-15 | 2019-02-20 | BioElectron Technology Corporation | Alkyl-heteroarylsubstituierte chinonderivate zur behandlung von oxidativen stresserkrankungen |
US9868711B2 (en) | 2013-03-15 | 2018-01-16 | Bioelectron Technology Corporation | Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders |
RU2578451C1 (ru) * | 2014-12-09 | 2016-03-27 | Государственное Бюджетное Образовательное Учреждение Высшего Профессионального Образования "Амурская Государственная Медицинская Академия" Министерства Здравоохранения Российской Федерации | Способ повышения устойчивости головного мозга к ишемии во время реконструктивных операций на брахиоцефальных артериях |
SI3233786T1 (sl) | 2014-12-16 | 2022-08-31 | PTC Therapeutics, Inc., | Polimorfne in amorfne oblike (R)-2-hidroksi-2-metil-4-(2,4,5-trimetil- 3,6-dioksocikloheksa-1,4-dienil)butanamida |
US10745371B2 (en) | 2015-12-16 | 2020-08-18 | Ptc Therapeutics, Inc. | Methods for enriching alpha-tocotrienol from mixed tocol compositions |
US10703701B2 (en) | 2015-12-17 | 2020-07-07 | Ptc Therapeutics, Inc. | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders |
JP7224916B2 (ja) | 2016-03-16 | 2023-02-20 | シダラ セラピューティクス インコーポレーテッド | 真菌感染の処置のための投薬レジメン |
US10707531B1 (en) | 2016-09-27 | 2020-07-07 | New Dominion Enterprises Inc. | All-inorganic solvents for electrolytes |
JP2018083799A (ja) | 2016-11-15 | 2018-05-31 | バイオエレクトロン テクノロジー コーポレイション | 2−置換アミノ−ナフト[1,2−d]イミダゾール−5−オン化合物またはその製薬学上許容される塩 |
EP3651801A4 (de) | 2017-07-12 | 2021-04-07 | Cidara Therapeutics, Inc. | Zusammensetzungen und verfahren zur behandlung von pilzinfektionen |
WO2020010180A1 (en) * | 2018-07-03 | 2020-01-09 | Cardio Vascular Bio Therapeutics, Inc. | Compositions and methods for treating stroke |
KR102337954B1 (ko) * | 2018-08-16 | 2021-12-10 | 차의과학대학교 산학협력단 | 뇌졸중 치료용 조성물 및 이를 스크리닝하는 방법 |
JP2022505257A (ja) | 2018-10-17 | 2022-01-14 | ピーティーシー セラピューティクス, インコーポレイテッド | α-シヌクレイノパチー、タウオパチー、および他の障害を抑制および処置するための2,3,5-トリメチル-6-ノニルシクロヘキサ-2,5-ジエン-1,4-ジオン |
US11584728B2 (en) | 2019-10-04 | 2023-02-21 | Stealth Biotherapeutics Inc. | Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia |
US20210162003A1 (en) * | 2019-10-17 | 2021-06-03 | The Penn State Research Foundation | Regenerating functional neurons for treatment of hemorrhagic stroke |
US12037350B2 (en) | 2020-04-03 | 2024-07-16 | Stealth Biotherapeutics Inc. | Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia |
CN113066113B (zh) * | 2021-04-27 | 2022-01-11 | 河北医科大学第二医院 | 自发性高血压大鼠脑模板和地图集的构建方法及设备 |
JP2024525232A (ja) | 2021-07-08 | 2024-07-10 | ピーティーシー セラピューティクス、インコーポレイテッド | 2,3,5-トリメチル-6-ノニルシクロヘキサ-2,5-ジエン-1,4-ジオンを含む医薬組成物 |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5938203B2 (ja) * | 1976-04-26 | 1984-09-14 | エーザイ株式会社 | 補酵素qを主成分とする脳循環障害治療剤 |
US5872108A (en) | 1995-03-06 | 1999-02-16 | Interneuron Pharmaceuticals, Inc. | Reduction of infarct volume using citicoline |
US6232060B1 (en) * | 1996-01-19 | 2001-05-15 | Galileo Laboratories, Inc. | Assay system for anti-stress agents |
US5801159A (en) * | 1996-02-23 | 1998-09-01 | Galileo Laboratories, Inc. | Method and composition for inhibiting cellular irreversible changes due to stress |
FR2753098B1 (fr) * | 1996-09-06 | 1998-11-27 | Sod Conseils Rech Applic | Composition pharmaceutique comprenant au moins un inhibiteur de no synthase et au moins un piegeur des formes reactives de l'oxygene |
ID26335A (id) | 1997-11-17 | 2000-12-14 | Lipogenic Inc | Metoda untuk mencegah restenosis dengan menggunakan tokotrienol |
US6048891A (en) * | 1998-12-17 | 2000-04-11 | Loma Linda University Medical Center | Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of natriuretic disease |
WO2000078296A2 (en) | 1999-06-17 | 2000-12-28 | Basf Aktiengesellschaft | Tocotrienol and/or tocotrienol derivatives for the treatment or prophylaxis of glutamate- and/or calcium-induced disorders |
US6426362B1 (en) * | 1999-10-08 | 2002-07-30 | Galileo Laboratories, Inc. | Formulations of tocopherols and methods of making and using them |
US6528042B1 (en) * | 1999-10-08 | 2003-03-04 | Galileo Laboratories, Inc. | Compositions of flavonoids for use as cytoprotectants and methods of making and using them |
US6346544B2 (en) * | 2000-03-02 | 2002-02-12 | Oklahoma Medical Research Foundation | Desmethyl tocopherols for protecting cardiovascular tissue |
DE10034233A1 (de) * | 2000-07-14 | 2002-01-24 | Basf Ag | Tocotrienolchinon-Cyclisierungsprodukte |
US20020132845A1 (en) * | 2000-12-15 | 2002-09-19 | Miller Guy Michael | Compositions and methods for the prevention and treatment of tissue ischemia |
US7034054B2 (en) * | 2000-12-15 | 2006-04-25 | Galileo Pharmaceuticals, Inc. | Methods for the prevention and treatment of cerebral ischemia using non-alpha tocopherols |
US6608196B2 (en) * | 2001-05-03 | 2003-08-19 | Galileo Pharmaceuticals, Inc. | Process for solid supported synthesis of pyruvate-derived compounds |
WO2003015494A2 (en) * | 2001-08-21 | 2003-02-27 | Galileo Pharmaceuticals, Inc. | Tocopherol enriched compositions and amelioration of inflammatory symptoms |
WO2003043570A2 (en) * | 2001-11-15 | 2003-05-30 | Galileo Laboratories, Inc. | Formulations and methods for treatment or amelioration of inflammatory conditions |
US20040152764A1 (en) * | 2001-12-14 | 2004-08-05 | Miller Guy M. | Compositions and methods for the prevention and treatment of cerebral ischemia |
US7078541B2 (en) * | 2002-02-07 | 2006-07-18 | Galileo Pharmaceuticals, Inc. | Benzofuran derivatives |
US6653346B1 (en) * | 2002-02-07 | 2003-11-25 | Galileo Pharmaceuticals, Inc. | Cytoprotective benzofuran derivatives |
US7491312B2 (en) * | 2002-10-30 | 2009-02-17 | Edison Pharmaceuticals, Inc. | Identifying therapeutic compounds based on their physical-chemical properties |
US7514461B2 (en) * | 2003-09-19 | 2009-04-07 | Edison Pharmaceuticals, Inc. | Chroman derivatives |
US7393662B2 (en) * | 2004-09-03 | 2008-07-01 | Centocor, Inc. | Human EPO mimetic hinge core mimetibodies, compositions, methods and uses |
DK1888059T3 (en) * | 2005-06-01 | 2015-03-30 | Edison Pharmaceuticals Inc | Redox-active therapeutic products for the treatment of mitochondrial diseases and other conditions as well as modulation of energy biomarkers |
DK1933821T3 (da) * | 2005-09-15 | 2020-10-26 | Ptc Therapeutics Inc | Halevarianter af redox-aktive terapeutika til behandling af mitokondriesygdomme og andre tilstande og modulation af energibiomarkører |
EA019675B1 (ru) * | 2006-02-22 | 2014-05-30 | Эдисон Фармасьютикалз, Инк. | Редокс-активные терапевтические средства для лечения митохондриальных заболеваний и модуляции биомаркера коэнзима q |
CA2674368A1 (en) * | 2007-01-10 | 2008-07-17 | Edison Pharmaceuticals, Inc. | Treatment of respiratory chain disorders using compounds having erythropoietin or thrombopoietin activity |
EP2220030B1 (de) * | 2007-11-06 | 2016-01-13 | Edison Pharmaceuticals, Inc. | 4-(p-chinonyl)-2-hydroxybutanamidderivate zur behandlung von mitochondrialen krankheiten |
US20100266591A1 (en) * | 2008-01-07 | 2010-10-21 | Peter Bugelski | Method of treating erythropoietin hyporesponsive anemias |
WO2009089224A1 (en) * | 2008-01-08 | 2009-07-16 | Edison Pharmaceuticals, Inc. | (HET) ARYL-p-QUINONE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES |
WO2009111576A2 (en) * | 2008-03-05 | 2009-09-11 | Edison Pharmaceuticals, Inc. | 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES |
EP2262519A4 (de) * | 2008-03-05 | 2011-03-23 | Edison Pharmaceuticals Inc | Behandlung von gehör- und gleichgewichtsstörungen mit redoxaktiven therapeutika |
CA2723621A1 (en) * | 2008-05-15 | 2009-11-19 | Edison Pharmaceuticals, Inc | Treatment of hearing and balance impairments using compounds having erythropoietin activity |
EP2303309A2 (de) * | 2008-05-22 | 2011-04-06 | Edison Pharmaceuticals, Inc. | Behandlung von mitochondrialen erkrankungen mit einem erythropoetin-mimetikum |
US8716486B2 (en) * | 2008-06-25 | 2014-05-06 | Edison Pharmaceuticals, Inc. | 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
US20100010100A1 (en) * | 2008-07-09 | 2010-01-14 | Hinman Andrew W | Dermatological compositions with anti-aging and skin even-toning properties |
WO2010014361A1 (en) * | 2008-07-30 | 2010-02-04 | Edison Pharmaceuticals, Inc. | Naphthoquinone compositions with anti-aging, anti- inflammatory and skin even-toning properties |
US8314153B2 (en) * | 2008-09-10 | 2012-11-20 | Edison Pharmaceuticals, Inc. | Treatment of pervasive developmental disorders with redox-active therapeutics |
US10039722B2 (en) * | 2008-10-14 | 2018-08-07 | Bioelectron Technology Corporation | Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells |
PL2963006T3 (pl) * | 2008-10-28 | 2019-01-31 | Bioelectron Technology Corporation | Kompozycja zawierająca chinon alfa-tokotrienolu, i jego związki pośrednie |
CA2760357A1 (en) * | 2009-04-28 | 2010-11-04 | Ampere Life Sciences, Inc. | Topical, periocular, or intraocular use of tocotrienols for the treatment of ophthalmic diseases |
CA2759984A1 (en) * | 2009-04-28 | 2010-11-04 | Edison Pharmaceuticals, Inc. | Formulation of tocotrienol quinones for the treatment of ophthalmic diseases |
NO2424495T3 (de) * | 2009-04-28 | 2018-06-16 | ||
MX2011013558A (es) * | 2009-06-25 | 2012-04-30 | Ampere Life Sciences Inc | Tratamiento del trastorno pervasivo del desarrollo con tocotrienoles o extractos de tocotrienoles enriquecidos. |
EP2519232A1 (de) * | 2009-12-31 | 2012-11-07 | Edison Pharmaceuticals, Inc. | Behandlung von leigh-syndrom und leigh-like-syndrom mit tocotrienolchinonen |
AU2011238525A1 (en) * | 2010-04-06 | 2012-11-08 | Edison Pharmaceuticals, Inc. | Treatment of Ataxia Telangiectasia |
AU2011245384C1 (en) * | 2010-04-27 | 2016-09-01 | Bioelectron Technology Corporation | Formulations of quinones for the treatment of ophthalmic diseases |
WO2012009271A1 (en) * | 2010-07-14 | 2012-01-19 | Penwest Pharmaceuticals Co. | Methods of providing anticoagulation effects in subjects |
US20120295985A1 (en) * | 2010-11-19 | 2012-11-22 | Miller Guy M | Methods for improving blood glucose control |
-
2010
- 2010-08-24 NO NO10747777A patent/NO2470168T3/no unknown
- 2010-08-24 EA EA201200355A patent/EA028677B1/ru not_active IP Right Cessation
- 2010-08-24 MX MX2012002374A patent/MX337990B/es active IP Right Grant
- 2010-08-24 CA CA2772294A patent/CA2772294C/en active Active
- 2010-08-24 HU HUE10747777A patent/HUE037592T2/hu unknown
- 2010-08-24 EP EP10747777.0A patent/EP2470168B1/de active Active
- 2010-08-24 AU AU2010286704A patent/AU2010286704B2/en not_active Ceased
- 2010-08-24 US US12/862,705 patent/US20110207828A1/en not_active Abandoned
- 2010-08-24 PT PT107477770T patent/PT2470168T/pt unknown
- 2010-08-24 ES ES10747777.0T patent/ES2663709T3/es active Active
- 2010-08-24 DK DK10747777.0T patent/DK2470168T3/en active
- 2010-08-24 WO PCT/US2010/046503 patent/WO2011025785A1/en active Application Filing
- 2010-08-24 JP JP2012526918A patent/JP5785546B2/ja not_active Expired - Fee Related
- 2010-08-24 CN CN201080048363.2A patent/CN102647981B/zh not_active Expired - Fee Related
- 2010-08-24 SI SI201031644T patent/SI2470168T1/en unknown
- 2010-08-24 BR BR112012004167A patent/BR112012004167A2/pt not_active Application Discontinuation
- 2010-08-24 PL PL10747777T patent/PL2470168T3/pl unknown
-
2015
- 2015-02-16 JP JP2015027506A patent/JP2015091899A/ja active Pending
-
2016
- 2016-02-10 US US15/040,961 patent/US20170007553A1/en not_active Abandoned
-
2018
- 2018-08-09 US US16/100,062 patent/US20180344667A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DK2470168T3 (en) | 2018-05-07 |
US20110207828A1 (en) | 2011-08-25 |
JP2015091899A (ja) | 2015-05-14 |
CN102647981A (zh) | 2012-08-22 |
US20170007553A1 (en) | 2017-01-12 |
EP2470168B1 (de) | 2018-01-31 |
US20180344667A1 (en) | 2018-12-06 |
CA2772294A1 (en) | 2011-03-03 |
CN102647981B (zh) | 2016-09-28 |
PT2470168T (pt) | 2018-03-28 |
BR112012004167A2 (pt) | 2016-03-29 |
MX2012002374A (es) | 2012-04-10 |
MX337990B (es) | 2016-03-30 |
ES2663709T3 (es) | 2018-04-16 |
SI2470168T1 (en) | 2018-05-31 |
AU2010286704B2 (en) | 2016-10-20 |
JP5785546B2 (ja) | 2015-09-30 |
EA201200355A1 (ru) | 2012-07-30 |
HUE037592T2 (hu) | 2018-09-28 |
PL2470168T3 (pl) | 2018-06-29 |
EA028677B1 (ru) | 2017-12-29 |
AU2010286704A1 (en) | 2012-03-22 |
CA2772294C (en) | 2018-08-21 |
WO2011025785A1 (en) | 2011-03-03 |
EP2470168A1 (de) | 2012-07-04 |
JP2013503168A (ja) | 2013-01-31 |